首页> 外文期刊>Hellenic Journal of Cardiology >Electrophysiology Catheter-Facilitated coronary sinus cannulation and implantation of cardiac resynchronization therapy systems
【24h】

Electrophysiology Catheter-Facilitated coronary sinus cannulation and implantation of cardiac resynchronization therapy systems

机译:电生理导管辅助冠状窦插管和心脏再同步治疗系统的植入

获取原文
           

摘要

Background Cardiac resynchronization therapy (CRT) device implantation is hampered by difficult placement of the left ventricular (LV) lead. We have routinely used a steerable electrophysiology catheter to guide coronary sinus (CS) cannulation and facilitate LV lead positioning. The aim of this prospective study is to present our results with this approach in 138 consecutive patients receiving a CRT device over 10?years. Methods The study included 120 men and 18 women, aged 64.8±11.4?years, with coronary disease (n=63), cardiomyopathy (n=72), or other disease (n=3), and mean ejection fraction of 24.5±4.5%. Devices were implanted for refractory heart failure and dyssynchrony, all but 2 in the presence of left bundle branch block. Implanted devices included biventricular pacemakers (CRT-P) (n=33) and cardioverter defibrillators (CRT-D) (n=105). Results Using the electrophysiology catheter, the CS could be engaged in 134 (97.1%) patients. In 4 patients failing CS cannulation, a dual-chamber device was implanted in 2, and bifocal right ventricular pacing was effected in 2. Bifocal (n=2) or conventional (n=1) systems were implanted in another 3 patients, in whom the LV lead got dislodged (n=2) or removed because of local dissection (n=1). Thus, finally, a CRT system was successfully established in 131 (94.9%) patients. There were 3 patients with CS dissection, of whom 1 was complicated by cardiac tamponade managed with pericardiocentesis. There were no perioperative deaths. During follow-up (31.0±21.2?months), clinical improvement was reported by 108 (82.4%) patients. Conclusion Routine use of an electrophysiology catheter greatly facilitated CS cannulation and successful LV lead placement in ~95% of patients undergoing CRT system implantation.
机译:背景技术心脏再同步治疗(CRT)设备的植入受左心室(LV)导线难以放置的阻碍。我们通常使用可操纵的电生理导管来引导冠状窦(CS)插管并促进LV导线定位。这项前瞻性研究的目的是在138位连续10年以上接受CRT装置的患者中采用这种方法介绍我们的结果。方法研究对象为120例男性和18例女性,年龄64.8±11.4岁,患有冠心病(n = 63),心肌病(n = 72)或其他疾病(n = 3),平均射血分数为24.5±4.5。 %。植入用于治疗难治性心力衰竭和不同步的装置,除2个装置外均在左束支传导阻滞的情况下植入。植入的设备包括双心室起搏器(CRT-P)(n = 33)和心脏复律除颤器(CRT-D)(n = 105)。结果使用电生理导管,CS可以参与134名患者(97.1%)。在4例CS插管失败的患者中,在2例中植入了双腔装置,在2例中进行了双焦点右心室起搏。另外3例患者中植入了双焦点(n = 2)或常规(n = 1)系统。 LV导线因局部解剖而脱落(n = 2)或被移除(n = 1)。因此,终于在131名患者中成功建立了CRT系统(94.9%)。有3例CS夹层患者,其中1例因心包填塞并经心包穿刺术而并发。没有围手术期死亡。在随访期间(31.0±21.2个月),据报告有108名患者(82.4%)临床改善。结论常规使用电生理导管极大地促进了约95%接受CRT系统植入的患者的CS插管和成功的LV引线放置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号